Lattice Biologics Ltd. ( TSX-V: LBL ) (OTCBB: LBLTF) (“Lattice Biologics” or the “Company”) has issued common shares and warrants pursuant to a litigation settlement. Pursuant to the litigation settlement Ms. Cheryl Farmer acquired 18,000,000 common shares of the Company representing 17.2% of the issued and outstanding common shares of the Company and 500,000 warrants of the Company. The common shares are subject to a
August 18, 2020
· 6 min read